Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Mild Alzheimer's patients benefit from 40Hz sensory stimulation in national clinical trial

At the Clinical Trials on Alzheimer's Disease conference in Boston Nov. 16, MIT spinoff company Cognito Therapeutics announced the results of its pivotal clinical trial of a noninvasive, device-based approach to Alzheimer's disease (AD) treatment first discovered in The Picower Institute in 2014. The "HOPE" trial included 663 people in two "prespecified" subgroups of volunteers: those with…

Mild Alzheimer's patients benefit from 40Hz sensory stimulation in national clinical trial

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

Map Shows Measles Cases Across America As Outbreak Reaches Newborns

The U.S. lost its measles-free status after officials determined the virus has been spreading continuously for over a year.

  • Map reveals over 5,412 measles cases across 45 states and D.C.
  • Pennsylvania leads with the most cases, followed by South Carolina and Wisconsin.
  • 13 congenital measles cases reported in newborns from 2025-2026.

More from Wednesday 18 November →